Related Experiment Video
Updated: Jun 28, 2026

14:14
Simultaneous Quantification of T-Cell Receptor Excision Circles (TRECs) and K-Deleting Recombination Excision Circles (KRECs) by Real-time PCR
Published on: December 6, 2014
Integrated bulk and single-cell transcriptomics identifies shared and specific immune signatures in Takayasu
Kexin Xu1, Taotao Li1, Na Gao1
1Department of Rheumatology and Immunology, Capital Medical University Affiliated Beijing Anzhen Hospital, Beijing, China.
Arthritis Research & Therapy
|November 11, 2025
Summary
This study reveals key gene networks in T cells driving Takayasu arteritis (TAK). EGR1 emerges as a central regulator, offering a potential therapeutic target for this large-vessel vasculitis.
Area of Science:
- Immunology
- Genomics
- Vascular Biology
Background:
- Takayasu arteritis (TAK) is a rare, chronic large-vessel vasculitis.
- CD4+ and CD8+ T cells are implicated in TAK pathogenesis, but their specific gene networks are not fully understood.
Purpose of the Study:
- To integrate bulk and single-cell RNA sequencing data to identify mechanistic biomarkers and therapeutic targets for TAK.
- To elucidate the gene expression profiles and intercellular communication networks of T cell subsets in TAK.
Main Methods:
- Bulk RNA sequencing of peripheral CD4+ and CD8+ T cells from TAK patients and healthy controls.
- Single-cell RNA sequencing of aortic tissue from TAK patients and atherosclerotic controls.
- Differential gene expression analysis, functional enrichment, protein-protein interaction network construction, and intercellular communication inference.
Main Results:
- Identified numerous differentially expressed genes (DEGs) in CD4+ and CD8+ T cells, enriched in inflammation, angiogenesis, and cytokine signaling pathways.
- Delineated CD4+-CD8+ T cell crosstalk in TAK aorta and identified heightened protein-homeostasis stress markers.
- Found consistent upregulation of transcriptional regulators EGR1, KLF4, RHOB, and ATF3 in both blood and tissue, with EGR1 playing a central role.
Conclusions:
- Integrated transcriptomics reveals shared and subset-specific T cell signaling in TAK.
- EGR1 is a pivotal molecular switch and a promising therapeutic target for TAK.
- Provides a mechanistic framework for precision immune modulation in large-vessel vasculitis.

